• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 3 fuera de 29 páginas
Examen

CMN 572 Unit 1 Exam Questions & Answers 2026/2027 | 161 Questions | Women’s Health, Contraception, STIs, Cervical Cancer & Vaginal Disorders

Document preview thumbnail
Vista previa 3 fuera de 29 páginas

This CMN 572 Unit 1 2026/2027 study guide contains 161 exam questions with correct answers across 29 pages, providing concentrated preparation for students studying women’s health and primary care. The document covers cervical cancer screening, HPV, abnormal cervical cytology, contraception, sexually transmitted infections, menstrual and vulvovaginal disorders, pelvic inflammatory disease, PCOS, endometriosis and reproductive health pharmacology. Its question-and-answer format combines factual recall with clinical decision-making, screening recommendations, diagnostic testing, medication selection, contraindications, patient education and follow-up. A major portion focuses on cervical cancer and HPV screening. Topics include the cervical transformation zone, CIN 2 and CIN 3, Pap cytology, HPV testing, ASC-US, ASC-H, LSIL, HSIL, AGC, NILM results and management of unsatisfactory cytology. The material also reviews decisions involving HPV-positive results, HPV 16/18 testing, repeat cytology, co-testing and indications for colposcopy. These questions provide students with practice interpreting cervical screening terminology and selecting the next clinical step according to the algorithms presented in the course material. The contraception section provides detailed coverage of combined oral contraceptives and progestin-only methods. Students review the ACHES warning signs, Sunday-start and quick-start approaches, backup contraception, breakthrough bleeding, estrogen sensitivity, migraines, postpartum contraception, smoking, obesity and contraceptive follow-up. The document also examines NuvaRing, transdermal patches, extended-cycle contraceptives, Depo-Provera, Mirena, Nexplanon, Paragard, diaphragms, condoms, contraceptive sponges, lactational amenorrhea and emergency contraception. Advantages, adverse effects, mechanisms of action and contraindications are emphasized throughout. Another substantial section covers sexually transmitted infections, including chlamydia, gonorrhea, syphilis, HSV, HPV and lymphogranuloma venereum. Students review transmission, incubation periods, clinical manifestations, NAAT testing, cultures, partner management, pregnancy considerations, screening and treatment regimens as presented in the source. Syphilis content includes primary and secondary disease, chancres, lymphadenopathy, treponemal and nontreponemal testing, the Jarisch-Herxheimer reaction and follow-up. HSV material covers primary and recurrent outbreaks, asymptomatic shedding, diagnostic testing, episodic therapy and suppressive antiviral treatment. The guide further addresses vaginal and gynecologic disorders, including PMS, endometriosis, lichen sclerosus, vulvodynia, candidiasis, bacterial vaginosis, trichomoniasis, atrophic vaginitis, cervical polyps, ovarian cysts and polycystic ovary syndrome. It reviews characteristic presentations such as clue cells and elevated vaginal pH in bacterial vaginosis, vulvar pruritus and discharge in candidiasis, and the distinctive discharge and examination findings associated with trichomoniasis. Diagnostic approaches covered include vaginal culture, wet mount, Gram stain, Amsel criteria and Nugent scoring. The final sections consolidate high-yield material on pelvic inflammatory disease, genital ulcers and contraceptive safety. Questions address the minimum diagnostic criteria for PID, its commonly associated organisms and treatment approach, as well as absolute contraindications to oral contraceptives, medication interactions and Depo-Provera considerations. Overall, the document is structured as a focused Unit 1 examination resource for rapidly reviewing clinical presentations, diagnostic tests, treatments, screening principles and medication counseling points. Relevant students: This resource is particularly relevant to CMN 572 students, Family Nurse Practitioner students, nurse practitioner students, advanced practice registered nursing students, graduate nursing students, women’s health students, primary care students, reproductive health learners and students preparing for clinical assessment or pharmacology examinations. The uploaded document does not identify the university offering CMN 572, so University Not Specified is used rather than assigning an unsupported institution. Keywords: CMN 572 Unit 1, CMN 572 exam questions and answers, CMN 572 Unit 1 exam, CMN , CMN 572 study guide, women’s health exam questions, nurse practitioner exam questions, FNP study guide, advanced practice nursing exam, cervical cancer screening, HPV screening, Pap smear questions, abnormal Pap smear, cervical cytology, ASC-US, ASC-H, LSIL, HSIL, colposcopy, contraception exam questions, oral contraceptives, combined oral contraceptives, progestin only contraception, Depo Provera, Nexplanon, Mirena IUD, Paragard IUD, emergency contraception, ACHES warning signs, sexually transmitted infections, STI exam questions, chlamydia, gonorrhea, syphilis, genital herpes, HPV, pelvic inflammatory disease, PID treatment, bacterial vaginosis, candidiasis, trichomoniasis, atrophic vaginitis, PCOS, endometriosis, reproductive health, women’s health pharmacology, primary care exam preparation, graduate nursing exam

Vista previa del contenido

CMN 572 Unit 1 2026/2027
Exam Questions and Correct
Answers | New Update



At what age does cervical cancer predominate? - ANSWER ✔✔40-44


When does HPV usually regress? - ANSWER ✔✔1-2 years


At what age should Pap smears be started? - ANSWER ✔✔21


What cervical cancer screening is done from age 21-29? - ANSWER

✔✔cytology every 3 years


What cervical cancer screenings are done at age 30-65? - ANSWER

✔✔cytology alone very 3 years or *preferred* co-testing (HPV and pap)

every 5 years

,What is considered high-grade precancerous lesion? - ANSWER

✔✔CIN 2 or 3


What should you get patient's to sign (especially younger patients) when

providing counseling on oral contraceptives? - ANSWER ✔✔an

informed consent and disclosure sheet that covers possible side effects

warning signs, drug interactions, and what to do if you forget one or two

pills


What are warning signs for oral contraceptives? - ANSWER

✔✔ACHES- Abd. pain (thrombosis), chest pain (PE or MI), Headaches

(stroke), eye problems (thrombosis), or severe leg pain (thrombosis)

How long is a back-up method recommended when starting oral

contraceptives? - ANSWER ✔✔7 days


What are the most common side effects of oral contraceptives? -

ANSWER ✔✔nausea and fatigue


When should OCs be started with a Sunday start? - ANSWER

✔✔The Sunday following the start of menses


What OC start method had the highest continuation rate? - ANSWER

✔✔Quick start- start on the day of office visit.

, When should a urine preg test be done when using the quick start

method? - ANSWER ✔✔if > 5 days since last menses and

unprotected sex

What patient education should be done for the first 3-6 months on

patients starting OC? - ANSWER ✔✔expect breakthrough bleeding,

take at same time everyday, taking in the evening can minimize side

effects

How often do women have menses on an extended cycle pill? -

ANSWER ✔✔once every 3-12 months


Medication strength for combination pills should not be greater than

what? - ANSWER ✔✔1/35 (progestin/estrogen)


Patients with a family history of what should get tested before beginning

oral contraceptives? - ANSWER ✔✔clotting disorders (Factor V

Leiden)

Patients with a family history of _____ before age _____ need to be

evaluated by a specialist before starting OCPs - ANSWER ✔✔CVD;

50

Patients with heavy bleeding should get what test before OCP start? -

ANSWER ✔✔platelet function test to r/o bleeding disorder


COPYRIGHT©NINJANERD 2026/2027. YEAR PUBLISHED 2026. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE. PRIVACY
STATEMENT. ALL RIGHTS RESERVED
3

Información del documento

Subido en
12 de septiembre de 2026
Número de páginas
29
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$21.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
NinjaNerd
3.4
(78)
Vendido
421
Seguidores
6
Artículos
15946
Última venta
2 días hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes